Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 225

1.

Prevalence of Myelin Oligodendrocyte Glycoprotein and Aquaporin-4-IgG in Patients in the Optic Neuritis Treatment Trial.

Chen JJ, Tobin WO, Majed M, Jitprapaikulsan J, Fryer JP, Leavitt JA, Flanagan EP, McKeon A, Pittock SJ.

JAMA Ophthalmol. 2018 Feb 22. doi: 10.1001/jamaophthalmol.2017.6757. [Epub ahead of print]

PMID:
29470571
2.

Glycine receptor modulating antibody predicting treatable stiff-person spectrum disorders.

Hinson SR, Lopez-Chiriboga AS, Bower JH, Matsumoto JY, Hassan A, Basal E, Lennon VA, Pittock SJ, McKeon A.

Neurol Neuroimmunol Neuroinflamm. 2018 Jan 23;5(2):e438. doi: 10.1212/NXI.0000000000000438. eCollection 2018 Mar.

3.

CSF free light chain identification of demyelinating disease: comparison with oligoclonal banding and other CSF indexes.

Gurtner KM, Shosha E, Bryant SC, Andreguetto BD, Murray DL, Pittock SJ, Willrich MAV.

Clin Chem Lab Med. 2018 Feb 19. pii: /j/cclm.ahead-of-print/cclm-2017-0901/cclm-2017-0901.xml. doi: 10.1515/cclm-2017-0901. [Epub ahead of print]

PMID:
29455184
4.

ITPR1 autoimmunity: Frequency, neurologic phenotype, and cancer association.

Alfugham N, Gadoth A, Lennon VA, Komorowski L, Scharf M, Hinson S, McKeon A, Pittock SJ.

Neurol Neuroimmunol Neuroinflamm. 2017 Dec 8;5(1):e418. doi: 10.1212/NXI.0000000000000418. eCollection 2018 Jan. No abstract available.

5.

MRI findings in glutamic acid decarboxylase associated autoimmune epilepsy.

Fredriksen JR, Carr CM, Koeller KK, Verdoorn JT, Gadoth A, Pittock SJ, Kotsenas AL.

Neuroradiology. 2018 Mar;60(3):239-245. doi: 10.1007/s00234-018-1976-6. Epub 2018 Jan 20.

PMID:
29353399
6.

Autoimmune Encephalitis Epidemiology and a comparison to Infectious Encephalitis.

Dubey D, Pittock SJ, Kelly CR, McKeon A, Lopez-Chiriboga AS, Lennon V, Gadoth A, Smith CY, Bryant SC, Klein CJ, Aksamit AJ, Toledano M, Boeve BF, Tilemma JM, Flanagan EP.

Ann Neurol. 2018 Jan 2. doi: 10.1002/ana.25131. [Epub ahead of print]

PMID:
29293273
7.

Calcium channel autoimmunity: Cerebellar ataxia and lambert-eaton syndrome coexisting.

Zalewski N, Lennon VA, Pittock SJ, Mckeon A.

Muscle Nerve. 2017 Dec 22. doi: 10.1002/mus.26053. [Epub ahead of print]

PMID:
29272039
8.

Composite ganglioside autoantibodies and immune treatment response in MMN and MADSAM.

Martinez-Thompson JM, Snyder MR, Ettore M, McKeon A, Pittock SJ, Roforth MM, Mandrekar J, Mauermann ML, Taylor BV, Dyck PJB, Windebank AJ, Klein CJ.

Muscle Nerve. 2017 Dec 22. doi: 10.1002/mus.26051. [Epub ahead of print]

PMID:
29272035
9.

Autoimmune CRMP5 neuropathy phenotype and outcome defined from 105 cases.

Dubey D, Lennon VA, Gadoth A, Pittock SJ, Flanagan EP, Schmeling JE, McKeon A, Klein CJ.

Neurology. 2018 Jan 9;90(2):e103-e110. doi: 10.1212/WNL.0000000000004803. Epub 2017 Dec 8.

PMID:
29222126
10.

Optic Disc Edema in Glial Fibrillary Acidic Protein Autoantibody-Positive Meningoencephalitis.

Chen JJ, Aksamit AJ, McKeon A, Pittock SJ, Weinshenker BG, Leavitt JA, Morris PP, Flanagan EP.

J Neuroophthalmol. 2017 Nov 21. doi: 10.1097/WNO.0000000000000593. [Epub ahead of print]

PMID:
29210929
11.

Neuromyelitis optica spectrum disorders and pregnancy: Interactions and management.

Shosha E, Pittock SJ, Flanagan E, Weinshenker BG.

Mult Scler. 2017 Dec;23(14):1808-1817. doi: 10.1177/1352458517740215.

PMID:
29154728
12.

Purkinje cell cytoplasmic antibody type I (anti-Yo): predictive of gastrointestinal adenocarcinomas in men.

Linnoila J, Guo Y, Gadoth A, Raghunathan A, Parks B, McKeon A, Lucchinetti CF, Lennon VA, Pittock SJ.

J Neurol Neurosurg Psychiatry. 2017 Nov 15. pii: jnnp-2017-316829. doi: 10.1136/jnnp-2017-316829. [Epub ahead of print] No abstract available.

PMID:
29142142
13.

Breast cancer-related paraneoplastic neurologic disease.

Murphy BL, Zalewski NL, Degnim AC, McKeon A, Flanagan EP, Pittock SJ, Habermann EB.

Breast Cancer Res Treat. 2018 Feb;167(3):771-778. doi: 10.1007/s10549-017-4566-0. Epub 2017 Nov 7.

PMID:
29116466
14.

B-cell-targeted therapies in relapsing forms of MS.

Dubey D, Forsthuber T, Flanagan EP, Pittock SJ, Stüve O.

Neurol Neuroimmunol Neuroinflamm. 2017 Oct 23;4(6):e405. doi: 10.1212/NXI.0000000000000405. eCollection 2017 Nov. Review.

15.

LGI1, CASPR2 and related antibodies: a molecular evolution of the phenotypes.

Binks SNM, Klein CJ, Waters P, Pittock SJ, Irani SR.

J Neurol Neurosurg Psychiatry. 2017 Oct 21. pii: jnnp-2017-315720. doi: 10.1136/jnnp-2017-315720. [Epub ahead of print] Review.

16.

Diagnostic criteria for chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS).

Tobin WO, Guo Y, Krecke KN, Parisi JE, Lucchinetti CF, Pittock SJ, Mandrekar J, Dubey D, Debruyne J, Keegan BM.

Brain. 2017 Sep 1;140(9):2415-2425. doi: 10.1093/brain/awx200.

PMID:
29050399
17.

PRES leading to the diagnosis of McArdle disease.

Martinez-Thompson JM, Pittock SJ, Milone M.

J Clin Neurosci. 2017 Dec;46:62-64. doi: 10.1016/j.jocn.2017.08.013. Epub 2017 Sep 5.

PMID:
28887083
18.

IgLON5 antibody: Neurological accompaniments and outcomes in 20 patients.

Honorat JA, Komorowski L, Josephs KA, Fechner K, St Louis EK, Hinson SR, Lederer S, Kumar N, Gadoth A, Lennon VA, Pittock SJ, McKeon A.

Neurol Neuroimmunol Neuroinflamm. 2017 Jul 18;4(5):e385. doi: 10.1212/NXI.0000000000000385. eCollection 2017 Sep.

19.

Dacrystic seizures-a cry for help.

Gadoth A, Singh J, Britton JW, Flanagan EP, Pittock SJ.

Neurol Neuroimmunol Neuroinflamm. 2017 Jun 16;4(4):e372. doi: 10.1212/NXI.0000000000000372. eCollection 2017 Jul. No abstract available.

20.

Expanded phenotypes and outcomes among 256 LGI1/CASPR2-IgG-positive patients.

Gadoth A, Pittock SJ, Dubey D, McKeon A, Britton JW, Schmeling JE, Smith A, Kotsenas AL, Watson RE, Lachance DH, Flanagan EP, Lennon VA, Klein CJ.

Ann Neurol. 2017 Jul;82(1):79-92. doi: 10.1002/ana.24979.

PMID:
28628235
21.

Autoimmune Neurology of the Central Nervous System.

Tobin WO, Pittock SJ.

Continuum (Minneap Minn). 2017 Jun;23(3, Neurology of Systemic Disease):627-653. doi: 10.1212/CON.0000000000000487.

PMID:
28570322
22.

Predictive models in the diagnosis and treatment of autoimmune epilepsy.

Dubey D, Singh J, Britton JW, Pittock SJ, Flanagan EP, Lennon VA, Tillema JM, Wirrell E, Shin C, So E, Cascino GD, Wingerchuk DM, Hoerth MT, Shih JJ, Nickels KC, McKeon A.

Epilepsia. 2017 Jul;58(7):1181-1189. doi: 10.1111/epi.13797. Epub 2017 May 26.

PMID:
28555833
23.

Disruption of the leptomeningeal blood barrier in neuromyelitis optica spectrum disorder.

Asgari N, Flanagan EP, Fujihara K, Kim HJ, Skejoe HP, Wuerfel J, Kuroda H, Kim SH, Maillart E, Marignier R, Pittock SJ, Paul F, Weinshenker BG.

Neurol Neuroimmunol Neuroinflamm. 2017 Apr 21;4(4):e343. doi: 10.1212/NXI.0000000000000343. eCollection 2017 Jul.

24.

Diagnosis and management of spinal cord emergencies.

Flanagan EP, Pittock SJ.

Handb Clin Neurol. 2017;140:319-335. doi: 10.1016/B978-0-444-63600-3.00017-9. Review.

PMID:
28187806
25.

Pathogenic implications of cerebrospinal fluid barrier pathology in neuromyelitis optica.

Guo Y, Weigand SD, Popescu BF, Lennon VA, Parisi JE, Pittock SJ, Parks NE, Clardy SL, Howe CL, Lucchinetti CF.

Acta Neuropathol. 2017 Apr;133(4):597-612. doi: 10.1007/s00401-017-1682-1. Epub 2017 Feb 9.

26.

Glial fibrillary acidic protein immunoglobulin G as biomarker of autoimmune astrocytopathy: Analysis of 102 patients.

Flanagan EP, Hinson SR, Lennon VA, Fang B, Aksamit AJ, Morris PP, Basal E, Honorat JA, Alfugham NB, Linnoila JJ, Weinshenker BG, Pittock SJ, McKeon A.

Ann Neurol. 2017 Feb;81(2):298-309. doi: 10.1002/ana.24881.

PMID:
28120349
27.

Association of Extension of Cervical Cord Lesion and Area Postrema Syndrome With Neuromyelitis Optica Spectrum Disorder.

Dubey D, Pittock SJ, Krecke KN, Flanagan EP.

JAMA Neurol. 2017 Mar 1;74(3):359-361. doi: 10.1001/jamaneurol.2016.5441. No abstract available.

PMID:
28097302
28.

Microtubule-associated protein 1B: Novel paraneoplastic biomarker.

Gadoth A, Kryzer TJ, Fryer J, McKeon A, Lennon VA, Pittock SJ.

Ann Neurol. 2017 Feb;81(2):266-277. doi: 10.1002/ana.24872.

PMID:
28074593
29.

Ring-enhancing spinal cord lesions in neuromyelitis optica spectrum disorders.

Zalewski NL, Morris PP, Weinshenker BG, Lucchinetti CF, Guo Y, Pittock SJ, Krecke KN, Kaufmann TJ, Wingerchuk DM, Kumar N, Flanagan EP.

J Neurol Neurosurg Psychiatry. 2017 Mar;88(3):218-225. doi: 10.1136/jnnp-2016-314738. Epub 2016 Dec 2.

PMID:
27913626
30.

A comparison of tissue-based and recombinant protein-based assays for detecting PCA-Tr/DNER-IgG.

Alfugham N, Roforth M, Komorowski L, Ott A, Meyer W, Probst C, Lennon VA, Pittock SJ, McKeon A.

Neurol Neuroimmunol Neuroinflamm. 2016 Oct 28;3(6):e294. eCollection 2016 Dec. No abstract available.

31.

Autoantibody-Associated Central Nervous System Neurologic Disorders.

Linnoila J, Pittock SJ.

Semin Neurol. 2016 Aug;36(4):382-96. doi: 10.1055/s-0036-1585453. Epub 2016 Sep 19.

PMID:
27643908
32.

Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy: A Novel Meningoencephalomyelitis.

Fang B, McKeon A, Hinson SR, Kryzer TJ, Pittock SJ, Aksamit AJ, Lennon VA.

JAMA Neurol. 2016 Nov 1;73(11):1297-1307. doi: 10.1001/jamaneurol.2016.2549.

PMID:
27618707
33.

Clinical-pathologic correlations in voltage-gated Kv1 potassium channel complex-subtyped autoimmune painful polyneuropathy.

Lahoria R, Pittock SJ, Gadoth A, Engelstad JK, Lennon VA, Klein CJ.

Muscle Nerve. 2017 Apr;55(4):520-525. doi: 10.1002/mus.25371. Epub 2017 Feb 13.

PMID:
27511450
34.

Clinical utility of testing AQP4-IgG in CSF: Guidance for physicians.

Majed M, Fryer JP, McKeon A, Lennon VA, Pittock SJ.

Neurol Neuroimmunol Neuroinflamm. 2016 Apr 20;3(3):e231. doi: 10.1212/NXI.0000000000000231. eCollection 2016 Jun.

35.

Preface.

Pittock SJ, Vincent A.

Handb Clin Neurol. 2016;133:ix. doi: 10.1016/B978-0-444-63432-0.09991-6. No abstract available.

PMID:
27112695
36.

Current and future immunotherapy targets in autoimmune neurology.

Hu MY, Stathopoulos P, O'connor KC, Pittock SJ, Nowak RJ.

Handb Clin Neurol. 2016;133:511-36. doi: 10.1016/B978-0-444-63432-0.00027-X. Review.

PMID:
27112694
37.

Autoimmune AQP4 channelopathies and neuromyelitis optica spectrum disorders.

Hinson SR, Lennon VA, Pittock SJ.

Handb Clin Neurol. 2016;133:377-403. doi: 10.1016/B978-0-444-63432-0.00021-9. Review.

PMID:
27112688
38.

Paraneoplastic and idiopathic autoimmune neurologic disorders: approach to diagnosis and treatment.

Pittock SJ, Palace J.

Handb Clin Neurol. 2016;133:165-83. doi: 10.1016/B978-0-444-63432-0.00010-4.

PMID:
27112677
39.

Introduction to autoimmune neurology.

Pittock SJ, Vincent A.

Handb Clin Neurol. 2016;133:3-14. doi: 10.1016/B978-0-444-63432-0.00001-3. Review.

PMID:
27112668
40.

Epidemiology of aquaporin-4 autoimmunity and neuromyelitis optica spectrum.

Flanagan EP, Cabre P, Weinshenker BG, St Sauver J, Jacobson DJ, Majed M, Lennon VA, Lucchinetti CF, McKeon A, Matiello M, Kale N, Wingerchuk DM, Mandrekar J, Sagen JA, Fryer JP, Borders Robinson A, Pittock SJ.

Ann Neurol. 2016 Feb 17. doi: 10.1002/ana.24617. [Epub ahead of print]

41.

Metabotropic glutamate receptor type 1 autoimmunity: Clinical features and treatment outcomes.

Lopez-Chiriboga AS, Komorowski L, Kümpfel T, Probst C, Hinson SR, Pittock SJ, McKeon A.

Neurology. 2016 Mar 15;86(11):1009-13. doi: 10.1212/WNL.0000000000002476. Epub 2016 Feb 17.

42.

Demyelinating disease: NMO spectrum disorders: clinical or molecular classification?

Pittock SJ.

Nat Rev Neurol. 2016 Mar;12(3):129-30. doi: 10.1038/nrneurol.2016.9. Epub 2016 Feb 5. No abstract available.

PMID:
26846455
43.

Neuromyelitis optica spectrum initially diagnosed as antiphospholipid antibody myelitis.

Guerra H, Pittock SJ, Moder KG, Froehling DA, Flanagan EP.

J Neurol Sci. 2016 Feb 15;361:204-5. doi: 10.1016/j.jns.2016.01.003. Epub 2016 Jan 5. No abstract available.

PMID:
26810544
44.

P/Q- and N-type calcium-channel antibodies: Oncological, neurological, and serological accompaniments.

Zalewski NL, Lennon VA, Lachance DH, Klein CJ, Pittock SJ, Mckeon A.

Muscle Nerve. 2016 Aug;54(2):220-7. doi: 10.1002/mus.25027. Epub 2016 Feb 8.

45.

Discriminating long myelitis of neuromyelitis optica from sarcoidosis.

Flanagan EP, Kaufmann TJ, Krecke KN, Aksamit AJ, Pittock SJ, Keegan BM, Giannini C, Weinshenker BG.

Ann Neurol. 2016 Mar;79(3):437-47. doi: 10.1002/ana.24582. Epub 2016 Feb 12.

PMID:
26677112
46.

Signal recognition particle immunoglobulin g detected incidentally associates with autoimmune myopathy.

Apiwattanakul M, Milone M, Pittock SJ, Kryzer TJ, Fryer JP, O'toole O, Mckeon A, Lennon VA.

Muscle Nerve. 2016 Jun;53(6):925-32. doi: 10.1002/mus.24970. Epub 2016 Feb 5.

47.

Monitoring oligoclonal immunoglobulins in cerebral spinal fluid using microLC-ESI-Q-TOF mass spectrometry.

Barnidge DR, Kohlhagen MC, Zheng S, Willrich MA, Katzmann JA, Pittock SJ, Murray DL.

J Neuroimmunol. 2015 Nov 15;288:123-6. doi: 10.1016/j.jneuroim.2015.09.011.

PMID:
26531705
48.

Basal ganglia T1 hyperintensity in LGI1-autoantibody faciobrachial dystonic seizures.

Flanagan EP, Kotsenas AL, Britton JW, McKeon A, Watson RE, Klein CJ, Boeve BF, Lowe V, Ahlskog JE, Shin C, Boes CJ, Crum BA, Laughlin RS, Pittock SJ.

Neurol Neuroimmunol Neuroinflamm. 2015 Oct 1;2(6):e161. doi: 10.1212/NXI.0000000000000161. eCollection 2015 Dec.

49.

Responses to and Outcomes of Treatment of Autoimmune Cerebellar Ataxia in Adults.

Jones AL, Flanagan EP, Pittock SJ, Mandrekar JN, Eggers SD, Ahlskog JE, McKeon A.

JAMA Neurol. 2015 Nov;72(11):1304-12. doi: 10.1001/jamaneurol.2015.2378.

PMID:
26414229
50.

Autoimmune Encephalitis in the ICU: Analysis of Phenotypes, Serologic Findings, and Outcomes.

Mittal MK, Rabinstein AA, Hocker SE, Pittock SJ, Wijdicks EF, McKeon A.

Neurocrit Care. 2016 Apr;24(2):240-50. doi: 10.1007/s12028-015-0196-8.

PMID:
26319044

Supplemental Content

Loading ...
Support Center